Literature DB >> 9622047

Risperidone-induced galactorrhea associated with a prolactin elevation.

A Popli1, S Gupta, S R Rangwani.   

Abstract

We report on the occurrence of galactorrhea associated with a prolactin elevation within weeks of treatment with risperidone. One of our patients was switched to a typical antipsychotic, with an improvement in the galactorrhea. The other patient was continued on risperidone due to a robust response, while her galactorrhea was partially treated with bromocriptine. The mechanism of prolactin elevation with risperidone is unclear. These cases suggest the need for further studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622047     DOI: 10.1023/a:1026150629199

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  4 in total

1.  Regarding "A Risperidone-induced Prolactinoma Resolved When A Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report".

Authors:  Danielle Coppola; Shanker Thiagarajah; Hong Qiu; David Hough
Journal:  Innov Clin Neurosci       Date:  2013-02

2.  Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.

Authors:  S R Tollin
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

3.  A risperidone-induced prolactinoma resolved when a woman with schizoaffective disorder switched to ziprasidone: a case report.

Authors:  Gail T Arcari; Asante K Mendes; Robert B Sothern
Journal:  Innov Clin Neurosci       Date:  2012-09

4.  Impact of Antipsychotics on Geriatric Patients: Efficacy, Dosing, and Compliance.

Authors:  Gerald A. Maguire
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.